Protective effect of COVID-19 vaccination against long COVID syndrome: A systematic review and meta-analysis
Background The relationship between coronavirus disease 2019 (COVID-19) vaccination
and long COVID has not been firmly established. We conducted a systematic review and …
and long COVID has not been firmly established. We conducted a systematic review and …
Characterization of the significant decline in humoral immune response six months post‐SARS‐CoV‐2 mRNA vaccination: a systematic review
KI Notarte, I Guerrero‐Arguero… - Journal of medical …, 2022 - Wiley Online Library
Accumulating evidence shows a progressive decline in the efficacy of coronavirus disease
2019 (COVID‐19)(severe acute respiratory syndrome coronavirus 2 [SARS‐CoV‐2]) …
2019 (COVID‐19)(severe acute respiratory syndrome coronavirus 2 [SARS‐CoV‐2]) …
Durability of immune response after COVID-19 booster vaccination and association with COVID-19 omicron infection
M Gilboa, G Regev-Yochay, M Mandelboim… - JAMA network …, 2022 - jamanetwork.com
Importance The BNT162b2 two-dose vaccine (BioNTech/Pfizer) has high effectiveness that
wanes within several months. The third dose is effective in mounting a significant immune …
wanes within several months. The third dose is effective in mounting a significant immune …
Humoral response in hemodialysis patients post-SARS-CoV-2 mRNA vaccination: a systematic review of literature
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the causative agent of
coronavirus disease 2019 (COVID-19), has infected over 600 million individuals and caused …
coronavirus disease 2019 (COVID-19), has infected over 600 million individuals and caused …
Effectiveness of inactivated COVID-19 vaccines against mild disease, pneumonia, and severe disease among persons infected with SARS-CoV-2 Omicron variant …
H Xu, H Li, H You, P Zhang, N Li, N Jiang… - Emerging microbes & …, 2023 - Taylor & Francis
It is critical to determine the real-world performance of vaccines against coronavirus disease
2019 (COVID-19) so that appropriate treatments and policies can be implemented. There …
2019 (COVID-19) so that appropriate treatments and policies can be implemented. There …
SARS-CoV-2 infection, vaccination, and antibody response trajectories in adults: a cohort study in Catalonia
M Karachaliou, G Moncunill, A Espinosa… - BMC medicine, 2022 - Springer
Background Heterogeneity of the population in relation to infection, COVID-19 vaccination,
and host characteristics is likely reflected in the underlying SARS-CoV-2 antibody …
and host characteristics is likely reflected in the underlying SARS-CoV-2 antibody …
The third dose of mRNA SARS-CoV-2 vaccines enhances the spike-specific antibody and memory B cell response in myelofibrosis patients
F Fiorino, A Ciabattini, A Sicuranza, G Pastore… - Frontiers in …, 2022 - frontiersin.org
Vaccination against SARS-CoV-2 using mRNA-based vaccines has been highly
recommended for fragile subjects, including myelofibrosis patients (MF). Available data on …
recommended for fragile subjects, including myelofibrosis patients (MF). Available data on …
Association of systemic adverse reaction patterns with long-term dynamics of humoral and cellular immunity after coronavirus disease 2019 third vaccination
M Yoshida, Y Kobashi, T Kawamura, Y Shimazu… - Scientific reports, 2023 - nature.com
The objective of this study was to clarify the impact of adverse reactions on immune
dynamics. We investigated the pattern of systemic adverse reactions after the second and …
dynamics. We investigated the pattern of systemic adverse reactions after the second and …
[HTML][HTML] Deciphering antiviral efficacy of malaria box compounds against malaria exacerbating viral pathogens-Epstein Barr virus and SARS-CoV-2, an in silico study
In malaria endemic countries, coinfections and cotransmissions of different viral pathogens
are widely reported. Prior studies have shown that malaria can trigger the Epstein-Barr virus …
are widely reported. Prior studies have shown that malaria can trigger the Epstein-Barr virus …
Incidence and predictors of breakthrough and severe breakthrough infections of SARS-CoV-2 after primary series vaccination in adults: a population-based survey of …
SM DeSantis, A Yaseen, T Hao… - The Journal of …, 2023 - academic.oup.com
Background Breakthrough infections of severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) are well documented. The current study estimates breakthrough incidence …
(SARS-CoV-2) are well documented. The current study estimates breakthrough incidence …